glp 1 agonist risks GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists Glucagon-like peptide-1 receptor agonists and
Description
C., & La Fleur, S

Circulating microRNAs Signature for Predicting Response to GLP1-RA Therapy in Type 2 Diabetic Patients: A Pilot Study

Int J Obes (Lond) 2024;48(8):11181125

Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression
